Horizon Therapeutics plc Announces Chief Financial Officer Succession Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Horizon Therapeutics (HZNP) PT Raised to $155 at Cowen
November 3, 2021 10:13 AM EDTCowen analyst Ken Cacciatore raised the price target on Horizon Therapeutics (NASDAQ: HZNP) to $155.00 (from $140.00) while maintaining an Outperform rating.
The analyst commented, "Tepezza's Q3 reached $616MM nicely above the Street as consistent demand continued and 2021 expectations for Tepezza are now $1.625B+... More
